Companies / Teladoc Health, Inc. / Activity
Activity — Teladoc Health, Inc.
96 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Divita Charles III CEO | Sell | Common Stock | $256.6K | -50K -13.27% | 327,862 0.18% of shares | medium |
| Mar 11, 2026 | Divita Charles III CEO | Sell | Common Stock | $152.2K | -28K -7.07% | 364,784 0.20% of shares | medium |
| Jun 2, 2026 | Divita Charles III CEO | Sell | Common Stock | $145.9K | -19K -4.68% | 389,894 0.21% of shares | medium |
| Mar 2, 2026 | Vandervoort Adam C Executive | Sell | Common Stock | $138.6K | -27K -20.78% | 103,239 0.06% of shares | medium |
| Mar 2, 2026 | Bliss Kelly Executive | Sell | Common Stock | $136.4K | -27K -23.92% | 84,747 0.05% of shares | medium |
| Jun 11, 2026 | Divita Charles III CEO | Sell | Common Stock | $125.5K | -18K -4.18% | 414,622 0.23% of shares | medium |
| Mar 3, 2026 | Rodrigues Fernando M. Executive | Sell | Common Stock | $125.0K | -25K -100.00% | 0 0.00% of shares | medium |
| Mar 2, 2026 | Nueno Carlos Executive | Sell | Common Stock | $103.2K | -20K -28.50% | 50,595 0.03% of shares | medium |
| Mar 2, 2026 | Rodrigues Fernando M. Executive | Sell | Common Stock | $83.5K | -16K -39.41% | 25,086 0.01% of shares | low |
| Jun 2, 2026 | Vandervoort Adam C Executive | Sell | Common Stock | $60.3K | -8K -6.69% | 110,261 0.06% of shares | low |
| Mar 2, 2026 | Catapano Joseph Ronald Executive | Sell | Common Stock | $6.8K | -1K -13.10% | 8,841 <0.01% of shares | low |
| Jan 5, 2026 | Catapano Joseph Ronald Executive | Sell | Common Stock | $5.4K | -758 -10.18% | 6,686 <0.01% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Restricted Stock Units | — | -9K -12.50% | 64,070 0.04% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Restricted Stock Units | — | -5K -25.00% | 16,050 <0.01% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Performance Stock Units | — | -426 -12.51% | 2,979 <0.01% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Common Stock | — | +9K +8.40% | 118,167 0.07% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Common Stock | — | +5K +5.16% | 109,015 0.06% of shares | low |
| Jun 1, 2026 | Vandervoort Adam C Executive | Exercise | Common Stock | — | +426 +0.41% | 103,665 0.06% of shares | low |
| Jun 10, 2026 | Divita Charles III CEO | Exercise | Restricted Stock Units | — | -39K -20.00% | 156,643 0.09% of shares | low |
| Jun 10, 2026 | Divita Charles III CEO | Exercise | Performance Stock Units | — | -4K -20.00% | 14,568 <0.01% of shares | low |
| Jun 10, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +39K +9.95% | 432,696 0.24% of shares | low |
| Jun 10, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +4K +0.93% | 393,536 0.22% of shares | low |
| Jun 1, 2026 | Divita Charles III CEO | Exercise | Restricted Stock Units | — | -42K -12.50% | 295,939 0.16% of shares | low |
| Jun 1, 2026 | Divita Charles III CEO | Exercise | Performance Stock Units | — | -2K -12.50% | 13,761 <0.01% of shares | low |
| Jun 1, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +42K +11.53% | 409,026 0.23% of shares | low |
| Jun 1, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +2K +0.54% | 366,750 0.20% of shares | low |
| May 21, 2026 | Fenwick Sandra L Director | Grant | Restricted Stock Units | — | +30K | 30,441 0.02% of shares | low |
| May 21, 2026 | Snow David B Jr Director | Grant | Restricted Stock Units | — | +30K | 30,441 0.02% of shares | low |
| May 20, 2026 | Snow David B Jr Director | Exercise | Restricted Stock Units | — | -29K -100.00% | 0 0.00% of shares | low |
| May 20, 2026 | Snow David B Jr Director | Exercise | Common Stock | — | +29K +34.49% | 113,032 0.06% of shares | low |
| May 21, 2026 | Shedlarz David L Director | Grant | Restricted Stock Units | — | +30K | 30,441 0.02% of shares | low |
| May 20, 2026 | Shedlarz David L Director | Exercise | Restricted Stock Units | — | -29K -100.00% | 0 0.00% of shares | low |
| May 20, 2026 | Shedlarz David L Director | Exercise | Common Stock | — | +30K +95.86% | 61,266 0.03% of shares | low |
| Mar 30, 2026 | Salka Susan R Director | Grant | Restricted Stock Units | — | +49K | 48,638 0.03% of shares | low |
| Mar 1, 2026 | Catapano Joseph Ronald Executive | Grant | Restricted Stock Units | — | +15K | 15,000 <0.01% of shares | low |
| Feb 27, 2026 | Catapano Joseph Ronald Executive | Exercise | Performance Stock Units | — | -155 -33.33% | 310 <0.01% of shares | low |
| Feb 27, 2026 | Catapano Joseph Ronald Executive | Grant | Performance Stock Units | — | +465 | 465 <0.01% of shares | low |
| Feb 27, 2026 | Catapano Joseph Ronald Executive | Exercise | Restricted Stock Units | — | -3K -33.33% | 6,667 <0.01% of shares | low |
| Feb 27, 2026 | Catapano Joseph Ronald Executive | Exercise | Common Stock | — | +155 +1.55% | 10,174 <0.01% of shares | low |
| Feb 27, 2026 | Catapano Joseph Ronald Executive | Exercise | Common Stock | — | +3K +49.85% | 10,019 <0.01% of shares | low |
| Jan 2, 2026 | Catapano Joseph Ronald Executive | Exercise | Restricted Stock Units | — | -2K -12.50% | 14,584 <0.01% of shares | low |
| Jan 2, 2026 | Catapano Joseph Ronald Executive | Exercise | Common Stock | — | +2K +38.85% | 7,444 <0.01% of shares | low |
| Feb 18, 2026 | Smith Michael S Director | Grant | Restricted Stock Units | — | +54K | 53,648 0.03% of shares | low |
| Mar 10, 2026 | Divita Charles III CEO | Exercise | Performance Stock Units | — | -25K -58.33% | 18,210 0.01% of shares | low |
| Mar 10, 2026 | Divita Charles III CEO | Grant | Performance Stock Units | — | +44K | 43,703 0.02% of shares | low |
| Mar 10, 2026 | Divita Charles III CEO | Exercise | Restricted Stock Units | — | -39K -16.67% | 195,803 0.11% of shares | low |
| Mar 10, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +25K +6.95% | 392,515 0.22% of shares | low |
| Mar 10, 2026 | Divita Charles III CEO | Exercise | Common Stock | — | +39K +11.94% | 367,022 0.20% of shares | low |
| Mar 1, 2026 | Nueno Carlos Executive | Grant | Restricted Stock Units | — | +173K | 173,010 0.10% of shares | low |
| Feb 27, 2026 | Nueno Carlos Executive | Exercise | Performance Stock Units | — | -1K -100.00% | 0 0.00% of shares | low |